🇺🇸 FDA
Pipeline program

Pevifoscorvir Sodium (ALG-000184)

ALG-000184-207

Phase 1 small_molecule active

Quick answer

Pevifoscorvir Sodium (ALG-000184) for Chronic Hepaititis B Infections is a Phase 1 program (small_molecule) at Aligos Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aligos Therapeutics
Indication
Chronic Hepaititis B Infections
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials